582 Companies
Amplia Therapeutics Limited, a pharmaceutical company, is currently working on developing FAK inhibitors for cancer and fibrosis. The lead molecule, AMP945, is a highly specific inhibitor. The comp...
Amplia Therapeutics Annual Report 2023Voyager Therapeutics, Inc., a biotech firm headquartered in Cambridge, Massachusetts, is making waves in the field of gene therapy and neurology disease treatment. The company's standout candidate ...
Voyager Therapeutics Inc Annual Report 2023Gossamer Bio, Inc., a clinical-stage biopharmaceutical company based in San Diego, is making waves in the medical community with its groundbreaking approach to discovering, acquiring, developing, a...
Gossamer Bio, Inc. Annual Report 2023Vertex Pharmaceuticals, a biotech firm specializing in treatments for cystic fibrosis (CF), has developed several therapies for CF patients with specific gene mutations. The company offers TRIKAFTA...
Vertex Pharmaceuticals Annual Report 2023Cytori is a prominent medical technology company that specializes in using adult regenerative cells from adipose tissue to help patients and physicians around the globe. The company’s devices and i...
Cytori Therapeutics Annual Report 2017Onconova Therapeutics, a clinical-stage biopharmaceutical company, has its sights set on developing innovative products for cancer treatment in the United States. Currently boasting two clinical-st...
Onconova Therapeutics Annual Report 2023Englewood, Colorado-based biopharmaceutical firm, Ampio Pharmaceuticals, Inc., has announced its continued pursuit of developing treatments for pain related to osteoarthritis. Specifically, the com...
Ampio Pharmaceuticals Annual Report 2023Aldeyra Therapeutics Inc., a biotech firm based in Lexington, Massachusetts, has been working tirelessly to develop and commercialize medicines aimed at treating immune-mediated diseases. One of it...
Aldeyra Therapeutics Inc Annual Report 2023Eidos Therapeutics, a clinical stage biopharmaceutical company, is generating buzz in the industry as it aims to address the large and growing unmet need in diseases caused by transthyretin (TTR) a...
Eidos Therapeutics, Inc. Annual Report 2018Ovid Therapeutics Inc. is taking strides in the development of vital medications for patients and families dealing with epilepsies and seizure-related neurological disorders across the United State...
Ovid Therapeutics Inc. Annual Report 2023Ocugen Sets Sights on Curing Blindness Diseases with Gene Therapies Clinical-stage biopharmaceutical company Ocugen, Inc. is on a mission to develop gene therapies capable of curing blindness dise...
Ocugen Annual Report 2023Hong Kong-based HUTCHMED (China) Limited is making strides in the field of targeted therapeutics and immunotherapies for the treatment of cancer and immunological diseases. Its portfolio of drugs i...
HUTCHMED (China) Annual Report 2023AdAlta is a groundbreaking biotechnology company that has developed a revolutionary platform for creating unique compounds called i-bodies. These compounds are created by mimicking the shape and st...
AdAlta Annual Report 2023Boston-based NeuroBo Pharmaceuticals, Inc. is leading the charge in developing and commercializing multimodal disease-modifying therapies for a range of diseases. With a focus on viral, neuropathic...
NeuroBo Pharmaceuticals, Inc. Annual Report 2023Arvinas, a clinical-stage biotechnology firm, is pioneering the development of therapies that degrade disease-causing proteins. The company has engineered proteolysis targeting chimeras (PROTAC) ta...
Arvinas Annual Report 2023